A rapidly advancing area of biomedical innovation is shining a spotlight on miR-128-3p, a small yet powerful molecule with the potential to reshape how diseases—especially cancer—are detected, ...
Researchers with the James P. Allison Institute™ at The University of Texas MD Anderson Cancer Center have discovered a new ...
Cancer researchers have spent decades cataloging mutations found in tumors, building databases that now hold millions of ...
Scientists have unveiled a powerful new tool called PerturbFate that could change how researchers tackle diseases driven by ...
Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse.
Researchers have identified how cells recognize and suppress transposons, mobile DNA elements that can destabilize genomes.
Outcomes of young-onset colorectal cancer vs late-onset colorectal cancer patients on phase 1 matched and non-matched therapies. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I.
Cancer cells travel through the blood like restless seeds, searching for places to take root. Yet one organ they almost never conquer is the very pump that carries them around the body: the heart. A ...
Marina Sirota had spent years building computational tools to match diseases with drugs that already exist. In mid-2025, her team at the University of California, San Francisco published the most ...
DNA methylation is a key epigenome component that helps dictate how genes are expressed, contributing to normal cell and tissue differentiation during development, as well as the process of biological ...